A new drug has been developed as a treatment for macular degeneration. The drug named Eylea will compete directly with Lucentis, the current leading treatment for the eye disease. It is expected … [Read more...]
iVeena Implants May Assist Macular Degeneration Patients
August 11, 2011 By Leave a Comment
Patients suffering from wet macular degeneration are usually treated with injections of Lucentis or Avastin. These intravitreal injections are described as painful and stressful. Fortunately … [Read more...]
Macular Degeneration Treatment Sorafenib
November 30, 2010 By Leave a Comment
Sorafenib, a drug traditionally used to treat cancer, has shown promise as a macular degeneration treatment. Most macular degeneration treatments concentrate on vascular endothelial grown factor … [Read more...]
Nova Scotia Funds Lucentis
October 29, 2010 By Leave a Comment
Nova Scotia has decided to fund Lucentis, the leading anti-vegf drug used for treating macular degeneration. Nova Scotia Health Minister Maureen MacDonald made the announcement about the macular … [Read more...]
Avastin and Lucentis Safe for Macular Degeneration Treatment
October 12, 2010 By Leave a Comment
A recent publication in the Archives of Ophthalmology reports that both Avastin and Lucentis are safe treatments for Macular Degeneration. Findings have shown that neither Avastin or Lucentis … [Read more...]
Recent Comments